Pieter E. Postmus
Leiden University Medical Center · 632 works · 37,526 citations · h-index 95
Top works
- The IASLC Lung Cancer Staging Project: Proposals for the Revision of the TNM Stage Groupings in the Forthcoming (Seventh) Edition of the TNM Classification of Malignant Tumours
- The IASLC Lung Cancer Staging Project: Proposals for Revision of the M Descriptors in the Forthcoming (Seventh) Edition of the TNM Classification of Lung Cancer
- Deletion of a DNA sequence at the chromosomal region 3p21 in all major types of lung cancer
- Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial
- Prophylactic Cranial Irradiation in Extensive Small-Cell Lung Cancer
- The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals Regarding the Clinical Staging of Small Cell Lung Cancer in the Forthcoming (Seventh) Edition of the Tumor, Node, Metastasis Classification for Lung Cancer
- Prognostic value of right ventricular mass, volume, and function in idiopathic pulmonary arterial hypertension
- Prognostic factors in patients with pleural mesothelioma: the European Organization for Research and Treatment of Cancer experience.
- The IASLC Lung Cancer Staging Project: Proposals Regarding the Relevance of TNM in the Pathologic Staging of Small Cell Lung Cancer in the Forthcoming (Seventh) Edition of the TNM Classification for Lung Cancer
- Randomized study of paclitaxel-cisplatin versus cisplatin-teniposide in patients with advanced non-small-cell lung cancer. The European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group.
- Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution
- Topotecan, a new active drug in the second-line treatment of small-cell lung cancer: a phase II study in patients with refractory and sensitive disease. The European Organization for Research and Treatment of Cancer Early Clinical Studies Group and New Drug Development Office, and the Lung Cancer Cooperative Group.
- Second-Line Chemotherapy in Relapsing or Refractory Non–Small-Cell Lung Cancer: A Review
- Current aspects of spontaneous pneumothorax
- Monitoring response to therapy in cancer using [ 18 F]-2-fluoro-2-deoxy- d -glucose and positron emission tomography: an overview of different analytical methods
- Fludarabine phosphate in the treatment of chronic lymphocytic leukemia.
- Pharmacokinetics of paclitaxel and carboplatin in a dose-escalating and dose-sequencing study in patients with non-small-cell lung cancer. The European Cancer Centre.
- Quantification of right ventricular afterload in patients with and without pulmonary hypertension
- The IASLC Lung Cancer Staging Project: Data Elements for the Prospective Project